Predicting the outcome of Sjogren's syndrome-associated non-hodgkin's lymphoma patients (scientific article)

Systemic involvement in primary Sjogren's syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry).

Q50484229

Treatment of mucosa-associated lymphoid tissue lymphoma in Sjogren's syndrome: a retrospective clinical study.

Q51015200

MALT lymphoma in patients with autoimmune diseases: a comparative analysis of characteristics and clinical course.

Q53548061

Clinical evolution, and morbidity and mortality of primary Sjögren's syndrome.

Q55033876

Prognosis and outcome of non-Hodgkin lymphoma in primary Sjögren syndrome.

Q55055463

Predicting adverse outcomes in primary Sjogren's syndrome: identification of prognostic factors

Q56907577

Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren's syndrome

Q56907636

Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: analysis of 75 patients

Q57012743

Risk, Predictors, and Clinical Characteristics of Lymphoma Development in Primary Sjögren's Syndrome

Q57901302

Autoimmune and Chronic Inflammatory Disorders and Risk of Non-Hodgkin Lymphoma by Subtype

Q63353115

Primary Sjögren's syndrome (SS) and malignant lymphoma. A retrospective cohort study of 55 patients with SS

Q71022588

Long-term followup of patients with Sjögren's syndrome

Q71634855

Probability of the development of non-Hodgkin's lymphoma in primary Sjögren's syndrome

Q71976155

Lymphomas in patients with Sjogren's syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses

Q73516588

Report of the Committee on Hodgkin's Disease Staging Classification

Q28250452

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

Q28251216

Toxicity and response criteria of the Eastern Cooperative Oncology Group

Q29619399

Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects

Q33386179

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

Q33773306

Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed

Q33825043

EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome

Q34117422

Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group

Q34523084

Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue

Q34529373

Clinical presentation and management of marginal zone lymphomas

Q34562804

Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome. Data at enrollment in the prospective ASSESS cohort

Q34743817

Non-gastric marginal zone B cell lymphoma: clinicopathologic features and treatment results

Q35534203

Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors

Q35637298

The risk of lymphoma development in autoimmune diseases: a meta-analysis

Q36313002

Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium

Q36528740

Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren's syndrome and association with disease activity and BAFF gene expression

Q36745815

Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies

Q37218079

The 2008 WHO classification of lymphomas: implications for clinical practice and translational research.

Q37653274

Increased Risk of Lymphoma in Sicca Syndrome

Q39632164

Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome

Q40634492

Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome

Q40650085

Most cases of primary salivary mucosa-associated lymphoid tissue lymphoma are associated either with Sjoegren syndrome or hepatitis C virus infection.

Q42985694

Dissemination patterns in non-gastric MALT lymphoma

Q44044817

Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjögren's syndrome

Q44554302

Role of Fms-like tyrosine kinase 3 ligand as a potential biologic marker of lymphoma in primary Sjögren's syndrome

Q46223982

Association of patterns of labial salivary gland inflammation with keratoconjunctivitis sicca. Analysis of 618 patients with suspected Sjögren's syndrome

Q46463584

Clinical features distinguishing lymphoma development in primary Sjögren's Syndrome--a retrospective cohort study

Q46512541

Assessment of the prognostic indices IPI and FLIPI in patients with mucosa-associated lymphoid tissue lymphoma.

Q46866801

Mortality and causes of death in primary Sjögren's syndrome: a prospective cohort study

Q47784216

P275

Creative Commons Attribution 4.0 International

copyrighted

issue

language of work or name

English

Q1860

P304

page(s)

e0116189

P577

publication date

2015-02-27

P1433

published in

PLOS One

Q564954

P1476

title

Predicting the outcome of Sjogren's syndrome-associated non-hodgkin's lymphoma patients

P478

volume

Reverse relations

cites work (P2860)

Q41652024	A BAFF receptor His159Tyr mutation in Sjögren's syndrome-related lymphoproliferation
Q33568158	Characterization and risk estimate of cancer in patients with primary Sjögren syndrome
Q47367551	Clinical features and outcome of lymphoma patients with pre-existing autoimmune diseases.
Q40785165	Cryoglobulinaemic vasculitis at diagnosis predicts mortality in primary Sjögren syndrome: analysis of 515 patients
Q39177903	Extrahepatic Manifestations of Primary Biliary Cholangitis
Q38645847	Is primary Sjögren's syndrome a risk factor for malignancies different from lymphomas? What does the literature highlight about it?
Q55446969	Lymphoma and Lymphomagenesis in Primary Sjögren's Syndrome.
Q93347159	Phosphatidylinositol 3-kinase delta pathway: a novel therapeutic target for Sjögren's syndrome
Q55284236	Prevalence of primary Sjögren's syndrome in patients undergoing evaluation for pulmonary arterial hypertension.
Q38905170	Primary Sjögren's syndrome: clinical phenotypes, outcome and the development of biomarkers
Q90258496	Pseudo-monoclonal gammopathy due to autoimmune disease: a case report
Q41535448	Pulmonary MALT Lymphoma in Patients with Sjögren's Syndrome
Q30234992	Reviewing primary Sjögren's syndrome: beyond the dryness - From pathophysiology to diagnosis and treatment
Q90415297	Role of miR200b-5p miRNA in lymphomagenesis associated with Sjögren's syndrome (SS)
Q89669149	Serum CXCL13 levels are associated with lymphoma risk and lymphoma occurrence in primary Sjögren's syndrome
Q39019614	Sjögren Syndrome and Other Causes of Sicca in Older Adults
Q64921582	Sjögren's Syndrome: Animal Models, Etiology, Pathogenesis, Clinical Subtypes, and Diagnosis.
Q52930950	The value of fine needle aspiration cytology in the clinical management of rare salivary gland tumors.
Q30249011	Treatment of primary Sjögren syndrome
Q90003803	Update on Sjögren Syndrome and Other Causes of Sicca in Older Adults

P819	ADS bibcode	2015PLoSO..1016189P
P356	DOI	10.1371/JOURNAL.PONE.0116189
P932	PMC publication ID	4344229
P698	PubMed publication ID	25723713
P5875	ResearchGate publication ID	273787575